Komori
Nissha (7915) · FactIncrease in the fair value of written put options

Written Put Options Relating to Non-Controlling Shareholders

First written in FY2024-Q1. 2 of 6 entries say "Advanced", first in FY2024-H1. Latest entry: FY2026-H1.

6entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2024-H1 – FY2024OtherFY2025-H1 – FY2026-H12024: 220242025: 220252026: 22026
Same theme, other companies
Recognition of Financial Liabilities for Put Options Written for Non-Controlling Interest ShareholdersA theme 8 companies write about · 5 as a headwind · 0 as a tailwind

5 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Increase in the fair value of written put optionsAnnual report

    「Written put options relating to non-controlling shareholders - - 4,301 4,463」

    The fair value of written put options relating to non-controlling shareholders increased from ¥4,301 million at the end of the previous fiscal year to ¥4,463 million.
  2. FY2025Decrease in the fair value of written put optionsAnnual report

    「Written put options relating to non-controlling shareholders 6,051 4,301」

    The fair value of written put options relating to non-controlling shareholders decreased from ¥6,051 million at the end of the previous fiscal year to ¥4,301 million.
  3. FY2025-H1Decrease in the fair value of written put optionsAnnual report

    「Written put options relating to non-controlling shareholders - - 5,601 5,601」

    The fair value of written put options relating to non-controlling shareholders decreased from ¥6,123 million at the end of the previous fiscal year to ¥5,601 million.
  4. FY2024AdvancedAnnual report

    「Written put options have been granted to the non-controlling shareholders of the acquired company. In principle, the fair value of the redemption amount is recognized as other financial liabilities (non-current), with an equal amount deducted from capital surplus.」

    Written put options granted to non-controlling shareholders in connection with the acquisitions of Isometric and Cathtek were recognized. Non-current financial liabilities at the end of the period amounted to ¥4,648 million, and capital surplus was also reduced.
  5. FY2024-H1Quantitative disclosure of the amount of written put optionsAnnual report

    「For the written put options on subsidiary interests granted by the Group to the owners of non-controlling interests, the present value of the redemption amount was recognized as a financial liability during the interim consolidated accounting period (see Note 12, “Financial Instruments”), with a corresponding reduction in capital surplus. As a result, capital surplus decreased by ¥3,027 million.」

    For the written put options granted to non-controlling shareholders in connection with the acquisition of Isometric, the fair value of the financial liability, ¥3,245 million, was disclosed, and capital surplus was reduced by ¥3,027 million.
  6. FY2024-Q1First statedAnnual report

    「The Group has granted written put options to the non-controlling shareholders of an acquired company. In principle, the present value of the redemption amount is recognized as other financial liabilities (non-current), with a corresponding reduction in capital surplus.」

    In connection with the acquisition of Isometric, written put options were granted to the non-controlling shareholders, and their present value was recognized as non-current financial liabilities, with a corresponding reduction in capital surplus.
Moved together

"Expanding Industrial Materials and Global Markets through M&A" moved the same way as this thread, in the same document, in 2 of its 6 moves.

2222★1234
  1. ★This thread
  2. 1Expanding Industrial Materials and Global Markets through M&A2×
  3. 2Improving profitability in the Industrial Materials business by reducing quality costs2×
  4. 3Expanding Medical Device Contract Manufacturing and Adding Value Across the Value Chain2×
  5. 4Lean Production and Manufacturing Efficiency Improvements Adapted to Demand Fluctuations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nissha yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Written Put Options Relating to Non-Controlling Shareholders | Nissha Co.,Ltd. (7915) | Komori